This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Sep;57(3):357-8.

doi: 10.1002/pbc.23135. Epub 2011 Apr 20.

L-asparaginase for treatment of childhood acute lymphoblastic leukemia: what have we learned?

Barbara L Asselin¹

Affiliations

PMID: 21509929
DOI: 10.1002/pbc.23135

Comment

L-asparaginase for treatment of childhood acute lymphoblastic leukemia: what have we learned?

Barbara L Asselin. Pediatr Blood Cancer. 2011 Sep.

. 2011 Sep;57(3):357-8.

doi: 10.1002/pbc.23135. Epub 2011 Apr 20.

Author

Barbara L Asselin¹

Affiliation

¹ Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA. barbara_asselin@urmc.rochester.edu

PMID: 21509929
DOI: 10.1002/pbc.23135

No abstract available

PubMed Disclaimer

Comment on

Five-year single-center study of asparaginase therapy within the ALL-BFM 2000 trial.
Schrey D, Speitel K, Lanvers-Kaminsky C, Gerss J, Möricke A, Boos J. Schrey D, et al. Pediatr Blood Cancer. 2011 Sep;57(3):378-84. doi: 10.1002/pbc.23041. Epub 2011 Feb 18. Pediatr Blood Cancer. 2011. PMID: 21337682 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley